Jacob Couturier1, James W Suliburk, Jeremy M Brown, David J Luke, Neeti Agarwal, Xiaoying Yu, Chi Nguyen, Dinakar Iyer, Claudia A Kozinetz, Paul A Overbeek, Michael L Metzker, Ashok Balasubramanyam, Dorothy E Lewis. 1. aDivision of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston bDepartment of Surgery, Baylor College of Medicine, Houston, Texas cDepartment of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana dDiabetes Research Center, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Baylor College of Medicine eDepartment of Pediatrics fDepartment of Molecular and Human Genetics gDepartment of Molecular and Cellular Biology, Baylor College of Medicine hEndocrine Service, Ben Taub General Hospital, Houston, Texas, USA.
Abstract
OBJECTIVE: The objective of this study is to determine whether adipose tissue functions as a reservoir for HIV-1. DESIGN: We examined memory CD4(+) T cells and HIV DNA in adipose tissue-stromal vascular fraction (AT-SVF) of five patients [four antiretroviral therapy (ART)-treated and one untreated]. To determine whether adipocytes stimulate CD4(+) T cells and regulate HIV production, primary human adipose cells were cocultured with HIV-infected CD4(+) T cells. METHODS: AT-SVF T cells were studied by flow cytometry, and AT-SVF HIV DNA (Gag and Env) was examined by nested PCR and sequence analyses. CD4(+) T-cell activation and HIV production were measured by flow cytometry and ELISA. RESULTS: AT-SVF CD3(+) T cells were activated (>60% CD69(+)) memory CD4(+) and CD8(+) T cells in uninfected and HIV-infected persons, but the AT-SVF CD4(+)/CD8(+) ratio was lower in HIV patients. HIV DNA (Gag and Env) was detected in AT-SVF of all five patients examined by nested PCR, comparably to other tissues [peripheral blood mononuclear cell (PBMC), lymph node or thymus]. In coculture experiments, adipocytes increased CD4(+) T-cell activation and HIV production approximately two to three-fold in synergy with gamma-chain cytokines interleukin (IL)-2, IL7 or IL15. These effects were mitigated by neutralizing antibodies against IL6 and integrin-α1β1. Adipocytes also enhanced T-cell viability. CONCLUSION: Adipose tissues of ART-treated patients harbour activated memory CD4(+) T cells and HIV DNA. Adipocytes promote CD4(+) T-cell activation and HIV production in concert with intrinsic adipose factors. Adipose tissue may be an important reservoir for HIV.
OBJECTIVE: The objective of this study is to determine whether adipose tissue functions as a reservoir for HIV-1. DESIGN: We examined memory CD4(+) T cells and HIV DNA in adipose tissue-stromal vascular fraction (AT-SVF) of five patients [four antiretroviral therapy (ART)-treated and one untreated]. To determine whether adipocytes stimulate CD4(+) T cells and regulate HIV production, primary human adipose cells were cocultured with HIV-infectedCD4(+) T cells. METHODS: AT-SVF T cells were studied by flow cytometry, and AT-SVF HIV DNA (Gag and Env) was examined by nested PCR and sequence analyses. CD4(+) T-cell activation and HIV production were measured by flow cytometry and ELISA. RESULTS: AT-SVF CD3(+) T cells were activated (>60% CD69(+)) memory CD4(+) and CD8(+) T cells in uninfected and HIV-infectedpersons, but the AT-SVF CD4(+)/CD8(+) ratio was lower in HIV patients. HIV DNA (Gag and Env) was detected in AT-SVF of all five patients examined by nested PCR, comparably to other tissues [peripheral blood mononuclear cell (PBMC), lymph node or thymus]. In coculture experiments, adipocytes increased CD4(+) T-cell activation and HIV production approximately two to three-fold in synergy with gamma-chain cytokines interleukin (IL)-2, IL7 or IL15. These effects were mitigated by neutralizing antibodies against IL6 and integrin-α1β1. Adipocytes also enhanced T-cell viability. CONCLUSION: Adipose tissues of ART-treated patients harbour activated memory CD4(+) T cells and HIV DNA. Adipocytes promote CD4(+) T-cell activation and HIV production in concert with intrinsic adipose factors. Adipose tissue may be an important reservoir for HIV.
Authors: M C Tellier; G Greco; M Klotman; A Mosoian; A Cara; W Arap; E Ruoslahti; R Pasqualini; L M Schnapp Journal: J Immunol Date: 2000-03-15 Impact factor: 5.422
Authors: Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante Journal: J Clin Invest Date: 2003-12 Impact factor: 14.808
Authors: Aina S Lihn; Bjørn Richelsen; Steen B Pedersen; Steen B Haugaard; Gulla Søby Rathje; Sten Madsbad; Ove Andersen Journal: Am J Physiol Endocrinol Metab Date: 2003-07-22 Impact factor: 4.310
Authors: Julia A Johnson; Jeanine B Albu; Ellen S Engelson; Susan K Fried; Yoritaro Inada; Gabriel Ionescu; Donald P Kotler Journal: Am J Physiol Endocrinol Metab Date: 2003-10-07 Impact factor: 4.310
Authors: Rebecca Rose; David J Nolan; Ekaterina Maidji; Cheryl A Stoddart; Elyse J Singer; Susanna L Lamers; Michael S McGrath Journal: AIDS Res Hum Retroviruses Date: 2017-08-07 Impact factor: 2.205
Authors: Martin Torriani; Suman Srinivasa; Kathleen V Fitch; Thomas Thomou; Kimberly Wong; Eva Petrow; C Ronald Kahn; Aaron M Cypess; Steven K Grinspoon Journal: J Clin Endocrinol Metab Date: 2016-01-12 Impact factor: 5.958
Authors: Salum J Lidenge; For Yue Tso; Owen Ngalamika; John R Ngowi; Yasaman Mortazavi; Eun Hee Kwon; Danielle M Shea; Veenu Minhas; Julius Mwaiselage; Charles Wood; John T West Journal: J Infect Dis Date: 2019-04-08 Impact factor: 5.226
Authors: Richard J Hodes; Felipe Sierra; Steven N Austad; Elissa Epel; Gretchen N Neigh; Kristine M Erlandson; Marissa J Schafer; Nathan K LeBrasseur; Christopher Wiley; Judith Campisi; Mary E Sehl; Rosario Scalia; Satoru Eguchi; Balakuntalam S Kasinath; Jeffrey B Halter; Harvey Jay Cohen; Wendy Demark-Wahnefried; Tim A Ahles; Nir Barzilai; Arti Hurria; Peter W Hunt Journal: Ann N Y Acad Sci Date: 2016-12 Impact factor: 5.691
Authors: Susanna L Lamers; Rebecca Rose; Lishomwa C Ndhlovu; David J Nolan; Marco Salemi; Ekaterina Maidji; Cheryl A Stoddart; Michael S McGrath Journal: J Neurovirol Date: 2015-11-16 Impact factor: 2.643